Increased Risk of Anemia in Patients with Asthma

References

• Jousilahti P, Salomaa V, Hakala K, et al. The association of sensitive systemic inflammation markers with bronchial asthma. Ann Allergy Asthma Immunol. 2002;89(4):381–385. doi:10.1016/S1081-1206(10)62039-X
   PubMed Web of Science ®Google Scholar
• Girdhar A, Kumar V, Singh A, et al. Systemic inflammation and its response to treatment in patients with asthma. Respir Care. 2011;56(6):800–805. doi:10.4187/respcare.00601
   PubMed Web of Science ®Google Scholar
• Liang Z, Liu L, Zhao H, et al. A systemic inflammatory endotype of asthma with more severe disease identified by unbiased clustering of the serum cytokine profile. Medicine. 2016;95(25):e3774. doi:10.1097/MD.0000000000003774
   PubMed Web of Science ®Google Scholar
• Weiss G, Ganz T, Goodnough LT. Anemia of inflammation. Blood. 2019;133:40–50. doi:10.1182/blood-2018-06-856500
   PubMed Web of Science ®Google Scholar
• Armitage AE, Eddowes LA, Gileadi U, et al. Hepcidin regulation by innate immune and infectious stimuli. Blood. 2011;118:4129–4139. doi:10.1182/blood-2011-04-351957
   PubMed Web of Science ®Google Scholar
• Nemeth E, Valore EV, Territo M, et al. Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood. 2003;101(7):2461–2463. doi:10.1182/blood-2002-10-3235
   PubMed Web of Science ®Google Scholar
• Theurl I, Mattle V, Seifert M, et al. Dysregulated monocyte iron homeostasis and erythropoietin formation in patients with anemia of chronic disease. Blood. 2006;107:4142–4148. doi:10.1182/blood-2005-08-3364
   PubMed Web of Science ®Google Scholar
• Boutou AK, Pitsiou GG, Stanopoulos I, et al. Levels of inflammatory mediators in chronic obstructive pulmonary disease patients with anemia of chronic disease: a case-control study. QJM. 2012;105(7):657–663. doi:10.1093/qjmed/hcs024
   PubMed Web of Science ®Google Scholar
• Hohaus S, Massini G, Giachelia M, et al. Anemia in hodgkin’s lymphoma: the role of interleukin-6 and hepcidin. J Clin Oncol. 2010;28(15):2538–2543. doi:10.1200/JCO.2009.27.6873
   PubMed Web of Science ®Google Scholar
• Falkensammer CE, Thurnher M, Leonhartsberger N, et al. C-reactive protein is a strong predictor for anaemia in renal cell carcinoma: role of IL-6 in overall survival. BJU Int. 2011;1072:1893–1898. doi:10.1111/j.1464-410X.2010.09817.x
   Google Scholar
• Jankowska EA, Rozentryt P, Witkowska A, et al. Iron deficiency: an ominous sign in patients with systolic chronic heart failure. Eur Heart J. 2010;31:1872–1880. doi:10.1093/eurheartj/ehq158
   PubMed Web of Science ®Google Scholar
• Drury KE, Schaeffer M, Silverberg JI. Association between atopic disease and anemia in US children. JAMA Pediatr. 2016;170(1):29–34. doi:10.1001/jamapediatrics.2015.3065
   PubMed Web of Science ®Google Scholar
• Rhew K, Brown JD, Oh JM. Atopic disease and anemia in Korean patients: cross-sectional study with propensity score analysis. Int J Environ Res Public Health. 2020;17(6):1978. doi:10.3390/ijerph17061978
   PubMed Web of Science ®Google Scholar
• Rhew K, Oh JM. Association between atopic disease and anemia in pediatrics: a cross-sectional study. BMC Pediatr. 2019;19(1):455. doi:10.1186/s12887-019-1836-5
   PubMed Web of Science ®Google Scholar
• Chang J-E, Lee H-M, Kim J, et al. Prevalence of anemia in pediatric patients according to asthma control: propensity score analysis. J Asthma Allergy. 2021;14:743–751. doi:10.2147/JAA.S318641
   PubMed Web of Science ®Google Scholar
• Ricciardolo FLM, Sorbello V, Folino A, et al. Identification of IL-17F/frequent exacerbator endotype in asthma. J Allergy Clin Immunol. 2017;140:395–406. doi:10.1016/j.jaci.2016.10.034
   PubMed Web of Science ®Google Scholar
• Turan N, Edwards MJ, Bates S, et al. IL-6 pathway upregulation in subgroup of severe asthma is associated with neutrophilia and poor lung function. Clin Exp Allergy. 2018;48:475–478. doi:10.1111/cea.13085
   PubMed Web of Science ®Google Scholar
• Raundhal M, Morse C, Khare A, et al. High IFN-γ and low SLPI mark severe asthma in mice and humans. J Clin Invest. 2015;125(8):3037–3050. doi:10.1172/JCI80911
   PubMed Web of Science ®Google Scholar
• Kim RY, Pinkerton JW, Essilfie AT, et al. Role for NLRP3 inflammasome-mediated, IL-1β-dependent responses in severe, steroid-resistant asthma. Am J Respir Crit Care Med. 2017;196:283–297. doi:10.1164/rccm.201609-1830OC
   PubMed Web of Science ®Google Scholar
• Vroman H, Bergen IM, van Hulst JAC, et al. TNF-α-induced protein 3 levels in lung dendritic cells instruct TH2 or TH17 cell differentiation in eosinophilic or neutrophilic asthma. J Allergy Clin Immunol. 2018;141:1620–1633. doi:10.1016/j.jaci.2017.08.012
   PubMed Web of Science ®Google Scholar
• Lachowicz-Scroggins ME, Dunican EM, Charbit AR, et al. Extracellular DNA, neutrophil extracellular traps, and inflammasome activation in severe asthma. Am J Respir Crit Care Med. 2019;199:1076–1085. doi:10.1164/rccm.201810-1869OC
   PubMed Web of Science ®Google Scholar
• Cooper AC, Mikhail A, Lethbridge MW, et al. Increased expression of erythropoiesis inhibiting cytokines (IFN-γ, TNF-α, IL-10, and IL-13) by T cells in patients exhibiting a poor response to erythropoietin therapy. J Am Soc Nephrol. 2003;14(7):1776–1784. doi:10.1097/01.ASN.0000071514.36428.61
   PubMed Web of Science ®Google Scholar
• Cavallaro F, Duca L, Pisani LF, et al. Anti-TNF-mediated modulation of prohepcidin improves iron availability in inflammatory bowel disease, in an IL-6-mediated fashion. Can J Gastroenterol Hepatol. 2017;2017:6843976. doi:10.1155/2017/6843976
   PubMed Web of Science ®Google Scholar
• Nemeth E, Rivera S, Gabayan V, et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest. 2004;113:1271–1276. doi:10.1172/JCI200420945
   PubMed Web of Science ®Google Scholar
• Markoulaki D, Kostikas K, Papatheodorou G, et al. Hemoglobin, erythropoietin and systemic inflammation in exacerbations of chronic obstructive pulmonary disease. Eur J Intern Med. 2011;22:103–107. doi:10.1016/j.ejim.2010.07.010
   PubMed Web of Science ®Google Scholar
• Panichi V, Migliori M, De Pietro S, et al. C reactive protein in patients with chronic renal diseases. Ren Fail. 2001;23:551–562. doi:10.1081/JDI-100104737
   PubMed Web of Science ®Google Scholar
• Bemelmans MH, Gouma DJ, Buurman WA. Influence of nephrectomy on tumor necrosis factor clearance in a murine model. J Immunol. 1993;150:2007–2017.
   PubMed Web of Science ®Google Scholar
• Abdel-Khalek MA, El-Barbary AM, Essa SA, et al. Serum hepcidin: a direct link between anemia of inflammation and coronary artery atherosclerosis in patients with rheumatoid arthritis. J Rheumatol. 2011;38:2153–2159. doi:10.3899/jrheum.110339
   PubMed Web of Science ®Google Scholar
• Chen Y, Xu W, Yang H, et al. Serum levels of hepcidin in rheumatoid arthritis and its correlation with disease activity and anemia: a meta-analysis. Immunol Invest. 2021;50(2–3):243–258. doi:10.1080/08820139.2020.1742731
   PubMed Web of Science ®Google Scholar
• Winn NC, Volk KM, Hasty AH. Regulation of tissue iron homeostasis: the macrophage “ferrostat”. JCI Insight. 2020;5(2):e132964. doi:10.1172/jci.insight.132964
   PubMed Web of Science ®Google Scholar
• Roth-Walter F. Iron-deficiency in atopic diseases: innate immune priming by allergens and siderophores. Front Allergy. 2022;3:859922. doi:10.3389/falgy.2022.859922
   PubMedGoogle Scholar
• Petje LM, Jensen SA, Szikora S, et al. Functional iron-deficiency in women with allergic rhinitis is associated with symptoms after nasal provocation and lack of iron-sequestering microbes. Allergy. 2021;76(9):2882–2886. doi:10.1111/all.14960
   PubMed Web of Science ®Google Scholar
• Nairz M, Weiss G. Iron in infection and immunity. Mol Aspects Med. 2020;75:100864. doi:10.1016/j.mam.2020.100864
   PubMed Web of Science ®Google Scholar
• Shaheen SO, Gissler M, Devereux G, et al. Maternal iron supplementation in pregnancy and asthma in the offspring: follow-up of a randomised trial in Finland. Eur Respir J. 2020;55(6):1902335. doi:10.1183/13993003.02335-2019
   PubMed Web of Science ®Google Scholar
• Collins AJ, Li S, Gilbertson DT, et al. Chronic kidney disease and cardiovascular disease in the medicare population. Kidney Int Suppl. 2003;87:S24–S31. doi:10.1046/j.1523-1755.64.s87.5.x
   PubMed Web of Science ®Google Scholar
• Sarnak MJ, Tighiouart H, Manjunath G, et al. Anemia as a risk factor for cardiovascular disease in The Atherosclerosis Risk in Communities (ARIC) study. J Am Coll Cardiol. 2002;40:27–33. doi:10.1016/S0735-1097(02)01938-1
   PubMed Web of Science ®Google Scholar
• Wouters HJCM, van der Klauw MM, de Witte T, et al. Association of anemia with health-related quality of life and survival: a large population-based cohort study. Haematologica. 2019;104:468–476. doi:10.3324/haematol.2018.195552
   PubMed Web of Science ®Google Scholar
• Engelkes M, de Ridder MA, Svensson E, et al. Multinational cohort study of mortality in patients with asthma and severe asthma. Respir Med. 2020;165:105919. doi:10.1016/j.rmed.2020.105919
   PubMed Web of Science ®Google Scholar
• To T, Stanojevic S, Moores G, et al. Global asthma prevalence in adults: findings from the cross-sectional world health survey [published correction appears in BMC Public Health. 2021 Oct 8;21(1):1809]. BMC Public Health. 2012;12:204. doi:10.1186/1471-2458-12-204
   PubMed Web of Science ®Google Scholar
• Ganz T. Anemia of Inflammation. N Engl J Med. 2019;381:1148–1157. doi:10.1056/NEJMra1804281
   PubMed Web of Science ®Google Scholar